SwePub
Sök i LIBRIS databas

  Utökad sökning

L773:1432 1041 OR L773:0031 6970
 

Sökning: L773:1432 1041 OR L773:0031 6970 > (2005-2009) > Potential drug inte...

  • Åstrand, EmelieHögskolan i Kalmar,Naturvetenskapliga institutionen,eHälsoinstitutet, Högskolan i Kalmar (författare)

Potential drug interactions during a three-decade study period : a cross-sectional study of a prescription register

  • Artikel/kapitelEngelska2007

Förlag, utgivningsår, omfång ...

  • 2007-06-28
  • Springer Science and Business Media LLC,2007
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:hik-620
  • https://urn.kb.se/resolve?urn=urn:nbn:se:hik:diva-620URI
  • https://doi.org/10.1007/s00228-007-0326-0DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • An erratum to this article can be found at http://dx.doi.org/10.1007/s00228-007-0374-5
  • Objectives  The increased risk of adverse events in patients receiving potentially interacting drugs has long been recognized. The purpose of the present study was to evaluate the change in the risk of receiving potentially interacting drugs during a period covering three decades and to examine the relative risk of actual drug combinations. Methods  The prescriptions from all individuals (about 8,000) with two or more prescriptions during three periods of 15 months, October to December 1983–1984, 1993–1994 and 2003–2004, were collected from an ongoing cohort study in the county of Jämtland, Sweden. The potential interactions were detected by a computerized system. Results  The relative risk (RR) of receiving potentially interacting drugs increased for type C interactions [RR: 1.177, 95% confidence interval (CI): 1.104–1.256] and decreased for type D interactions (RR: 0.714, 95% CI: 0.587–0.868) from the period 1983–1984 to 2003–2004. Polypharmacy for the participants increased by 61%, from 9.05 filled prescriptions per subject in 1983–1984 to 10.6 in 1993–1994 and 14.6 in 2003–2004. The RR was positively correlated to the pronounced increase in polypharmacy; in addition, an exponential relationship was found for the more severe type D interactions. Few interacting drug combinations were responsible for a large proportion of the risk. Conclusion  We conclude that the risk of receiving potentially interacting drugs was strongly correlated to the concomitant use of multiple drugs. The pronounced increase in polypharmacy over time implies a growing reason for prescribers and pharmacists to be aware of drug interactions. Recently established national prescription registers should be evaluated for drug interaction vigilance, both clinically and epidemiologically.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Åstrand, BengtHögskolan i Kalmar,Naturvetenskapliga institutionen,Apoteket AB(Swepub:lnu)fasbe (författare)
  • Antonov, KarolinaThe Association of Pharmaceutical IndustryStockholm (författare)
  • Petersson, GöranHögskolan i Kalmar,Humanvetenskapliga institutionen,eHälsoinstitutet, Högskolan i Kalmar(Swepub:lnu)epego (författare)
  • Högskolan i KalmarNaturvetenskapliga institutionen (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:European Journal of Clinical Pharmacology: Springer Science and Business Media LLC63:9, s. 851-8590031-69701432-1041

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy